HCPCS Level IIdrugActive
J1573
Hepagam b intravenous, inj
BETOS: O1E
Effective: 2009-01-01
Referenced in 2 policies
Description
Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Hepagam B
Manufacturer
Kamada Ltd.
HCPCS Dosage
0.5 ML
Billing Units
10.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.